Skip to main content
Shree Hari Chemicals Export Ltd. logo

Shree Hari Chemicals Export Ltd. — Investor Relations & Filings

Ticker · 524336 ISIN · INE065E01017 LEI · 335800J5JFKA4UDD5P03 BSE.NS Manufacturing
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS 524336

About Shree Hari Chemicals Export Ltd.

https://shreeharichemicals.in/

Shree Hari Chemicals Export Ltd. specializes in the manufacturing and export of dye intermediates, with a primary focus on H-Acid (1-Amino 8-Naphthol 3,6 Disulphonic Acid). The company utilizes specialized chemical synthesis processes to produce intermediates essential for the formulation of reactive dyes. These products serve diverse applications across the textile, leather, and paper sectors. The organization emphasizes large-scale production capabilities and maintains technical standards to ensure product consistency for its global client base. Its operations are centered on the efficient synthesis of complex organic compounds used in industrial coloring processes.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the FY 2025-2026
Regulatory Filings Classification · 85% confidence The document is a Secretarial Compliance Report prepared under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and submitted to BSE Ltd. It is essentially an officer attestation/certification by the Company Secretary and statutory practitioners regarding compliance, without containing actual financial statements or detailed report content. Under the “CERTIFICATION RULE,” such attestation/certification filings default to Regulatory Filings (RNS).
2026-05-21 English
Statement under regulation 32(1) for the quarter ended 31.03.2026
Regulatory Filings Classification · 75% confidence The document is a formal disclosure under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing a statement of deviations or variations in the use of proceeds from a preferential issue for the quarter ended March 31, 2026. It is a compliance announcement to the stock exchange rather than a standalone financial report, earnings release, management presentation, or capital raising announcement. It does not constitute a full interim report or annual report but is a regulatory filing. Therefore, it falls under the “Regulatory Filings” category (RNS).
2026-05-15 English
Results-31-03-2026
Interim / Quarterly Report Classification · 85% confidence The document is a SEBI exchange filing dated May 15, 2026, titled “Audited Financial Statements and Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31.03.2026.” It contains actual financial statements (balance sheet, cash flow statement, profit & loss, comprehensive income, notes) and an independent auditor’s report. It is filed for quarterly (and year‐end) results under SEBI Listing Regulation 33, and includes substantive financial data rather than merely announcing or linking to a report. This matches the criteria for an Interim / Quarterly Report (IR) since it provides comprehensive financial data for a period shorter than a full fiscal year (the quarter), plus the year‐end audited figures. Therefore, the correct classification is IR. FY 2026
2026-05-15 English
Audited Financial statements & results for the quarter and year ended 31.03.2026
Interim / Quarterly Report Classification · 92% confidence The document is a Regulation 33 disclosure to BSE including the full audited standalone financial statements (balance sheet, cash flows, P&L), quarterly audited results for Q4 (with year‐to‐date figures), and auditor’s report for the year ended March 31, 2026. It is not merely an announcement or a proxy, nor a full annual report narrative. It fits the definition of an Interim/Quarterly Report as it contains substantive financial statements for a quarterly period (with year‐end comparatives). FY 2026
2026-05-15 English
Shree Hari Chemicals Export Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Audited Financial ....
Regulatory Filings Classification · 95% confidence The document is a letter from the company to the stock exchange informing about the upcoming Board Meeting scheduled to approve the audited financial statements and results for the fiscal year ended March 31, 2026. It also mentions the recommendation of dividend and the reopening of the trading window. The document is short (1701 characters) and serves as a notification of an event (Board Meeting) and upcoming financial results, not the financial report itself. It is a regulatory announcement pursuant to SEBI regulations, informing about the meeting and related compliance matters. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than the actual Annual Report or Earnings Release.
2026-05-08 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.